{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Histamine-3 receptor antagonists", "item": "https://www.patentleaderboard.com/patent/7812040"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Histamine-3 receptor antagonists

Histamine-3 receptor antagonists

US Patent 7812040 · Granted Oct 12, 2010

Estimated economic value: $603,448,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Tricyclic compounds and their use as phosphodiesterase inhibitors2022
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors2022
Cyclic substituted imidazo[4,5-c]quinoline derivatives2021
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds2020
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands2020
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds2019
Pyrazolopyrimidine compounds2018
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2018
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[22017
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors2017